20512580

Source:http://linkedlifedata.com/resource/pubmed/id/20512580

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:20512580	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:20512580	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:20512580	lifeskim:mentions	umls-concept:C0278678	lld:lifeskim
pubmed-article:20512580	lifeskim:mentions	umls-concept:C0003250	lld:lifeskim
pubmed-article:20512580	lifeskim:mentions	umls-concept:C0540128	lld:lifeskim
pubmed-article:20512580	lifeskim:mentions	umls-concept:C1519043	lld:lifeskim
pubmed-article:20512580	lifeskim:mentions	umls-concept:C0205210	lld:lifeskim
pubmed-article:20512580	lifeskim:mentions	umls-concept:C1709068	lld:lifeskim
pubmed-article:20512580	pubmed:issue	1	lld:pubmed
pubmed-article:20512580	pubmed:dateCreated	2011-1-21	lld:pubmed
pubmed-article:20512580	pubmed:abstractText	To evaluate the efficacy and safety of WX-G250, a chimeric monoclonal antibody that binds to carboxy anhydrase IX, combined with low-dose interferon-alpha (LD-IFN?) in patients with progressive metastatic renal cell carcinoma (mRCC).	lld:pubmed
pubmed-article:20512580	pubmed:language	eng	lld:pubmed
pubmed-article:20512580	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:20512580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20512580	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:20512580	pubmed:month	Feb	lld:pubmed
pubmed-article:20512580	pubmed:issn	1433-8726	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:HofmannRR	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:BeckJJ	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:StielEE	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:SiebelsMM	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:StahlerMM	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:ObernederRR	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:KindlerMM	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:RohrmannKK	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:HasekeNN	lld:pubmed
pubmed-article:20512580	pubmed:author	pubmed-author:KloepferPP	lld:pubmed
pubmed-article:20512580	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:20512580	pubmed:volume	29	lld:pubmed
pubmed-article:20512580	pubmed:owner	NLM	lld:pubmed
pubmed-article:20512580	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:20512580	pubmed:pagination	121-6	lld:pubmed
pubmed-article:20512580	pubmed:dateRevised	2011-11-17	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:meshHeading	pubmed-meshheading:20512580...	lld:pubmed
pubmed-article:20512580	pubmed:year	2011	lld:pubmed
pubmed-article:20512580	pubmed:articleTitle	A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients.	lld:pubmed
pubmed-article:20512580	pubmed:affiliation	Department of Urology, University of Munich, Marchioninistr. 15, 81377, Munich, Germany. michael.siebels@urologiepasing.de	lld:pubmed
pubmed-article:20512580	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:20512580	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:20512580	pubmed:publicationType	Multicenter Study	lld:pubmed
pubmed-article:20512580	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed
pubmed-article:20512580	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed